Company Focus
Moderna
Latest Moderna News
Biotechnology
Moderna has reported third-quarter 2024 revenues of $1.9 billion, marking a slight increase from the $1.8 billion posted in the same period in 2023. 7 November 2024
Related News
Insights
Company Spotlight
A biopharma company developing products for the treatment of human disease, including immunology, metabolism, cardiology and ophthalmology.
Latest News & Features of interest to Moderna
Biotechnology
Swedish Orphan Biovitrum, the Nordic biotech company known as Sobi, today announced financial results for the second quarter of 2024. 16 July 2024
Biotechnology
Côte d’Ivoire has become the first country to begin administering the new R21/Matrix-M vaccine. 16 July 2024
Pharmaceutical
The USA's BARDA has announced up to $500 million in Project NextGen funding to plan and execute multiple Phase IIb clinical trials evaluating novel vaccines administered as a nasal spray or as a pill to protect against symptomatic COVID-19. 16 July 2024
Biotechnology
M&A news last week featured US pharma major Eli Lilly announcing a $3.2 billion bid to acquire gastroenterology specialist Morphic. On the research front, US clinical-stage biotech HilleVax announced disappointing Phase IIb results with its norovirus vaccine HIL-214. Also, Dutch firm uniQure pleased investors with early--stage results for its investigational Huntington’s disease drug AMT-130, and US pharma gian
t Pfizer announced it is progressing its Parkinson’s disease candidate danuglipron. 14 July 2024
Biotechnology
Australian biotech Immutep has announced positive results from Cohort B of the TACTI-003 (KEYNOTE-PNC-34) Phase IIb trial evaluating eftilagimod alfa (efti) in combination with Keytruda (pembrolizumab). 12 July 2024
Pharmaceutical
Phesi, a clinical development analytics company, has released its mid-year analysis for 2024. 11 July 2024
Biotechnology
German drug discovery and development company Evotec has entered into a multi-year master research collaboration and option and license agreement with US pharma giant Pfizer. 11 July 2024
Pharmaceutical
French pharma major Sanofi has started shipping its first influenza vaccines across the USA in preparation for the 2024/25 flu season. 11 July 2024
Biotechnology
Shares of Dutch gene therapy company uniQure were up more than 50% at $5.68, after the company released positive early clinical results for its Huntington’s disease candidate. 9 July 2024
Latest In Brief for Moderna
Biotechnology
GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS). 4 October 2024
Latest Relevant Ones To Watch News
California, USA-based biotech Nektar Therapeutics’ shares closed up more than 8% at $1.33 yesterday after it announced the sale of its only manufacturing facility. 5 November 2024
18 October 2024
24 September 2024
23 September 2024
16 September 2024
23 August 2024
22 August 2024
Relevant Ones to Watch Companies
Refine Search
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze